Status:
ENROLLING_BY_INVITATION
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
Lead Sponsor:
Eye Hospital Pristina Kosovo
Conditions:
Pseudophakia
Myopia
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantat...
Detailed Description
The residual myopic refraction after 6 month on pseudophakic patients using Relex-Smile surgery using VisuMax Femtosecond Laser.The residual myopic refractive power is between -0.75D till -5.50D.The o...
Eligibility Criteria
Inclusion
- residual myopic refraction -0.75d till -5.50D
- complain visual acuity regarding residual myopic refraction
Exclusion
- active anterior segment pathologic features
- previous corneal or anterior segment surgery
- glaucoma
- history of ocular inflammation
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04693663
Start Date
June 1 2017
End Date
June 1 2026
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Hospital Pristina
Pristina, Kosovo, 10000